Chabás A, Gort L, Montfort M, Castelló F, Domínguez M C, Grinberg D, Vilageliu L
Institut de Bioquímica Clínica, Planta Baixa, Barcelona, Spain.
J Med Genet. 1998 Sep;35(9):775-7. doi: 10.1136/jmg.35.9.775.
Gaucher disease results, in most patients, from mutations in the gene encoding glucocerebrosidase. Mutation D409H is the third most frequent in Spanish patients, accounting for 5.7% of all mutated alleles. This allele is associated mainly with the neurological forms of the disease. Recently, homozygosity for the D409H mutation has been associated with a particular phenotype, including specific cardiovascular symptoms. Here we report a second Spanish patient bearing the D409H/D409H genotype with a very early manifestation of the disease. The patient started enzyme replacement therapy at 3 months of age. A common origin for the Spanish D409H alleles was ruled out by haplotype analysis using an internal polymorphism of the glucocerebrosidase gene and two external microsatellite markers.
在大多数患者中,戈谢病是由编码葡萄糖脑苷脂酶的基因突变引起的。D409H突变是西班牙患者中第三常见的突变,占所有突变等位基因的5.7%。该等位基因主要与该疾病的神经学形式相关。最近,D409H突变的纯合性与一种特定的表型相关,包括特定的心血管症状。在此,我们报告了第二例患有D409H/D409H基因型的西班牙患者,该患者疾病表现非常早。该患者在3个月大时开始接受酶替代疗法。通过使用葡萄糖脑苷脂酶基因的内部多态性和两个外部微卫星标记进行单倍型分析,排除了西班牙D409H等位基因的共同起源。